<DOC>
	<DOC>NCT00808977</DOC>
	<brief_summary>The purpose of the study is to obtain a first clinical assessment of the safety of dersalazine sodium in ulcerative colitis patients with mild to moderate disease.</brief_summary>
	<brief_title>A Phase II Study to Explore the Safety and Activity of Dersalazine in Patients With Mild to Moderate Ulcerative Colitis</brief_title>
	<detailed_description />
	<mesh_term>Ulcer</mesh_term>
	<mesh_term>Colitis, Ulcerative</mesh_term>
	<mesh_term>Colitis</mesh_term>
	<mesh_term>Mesalamine</mesh_term>
	<criteria>Age 18 to 65 inclusive Male, nonchildbearing female or fertile female with appropriate contraception. Mild to moderate confirmed active ulcerative colitis Able and willing to give informed consent Colitis of other cause Pregnancy, inadequate contraception for fertile female patients Liver or kidney disease, unstable cardiovascular disease, coagulation disorder. Other significant medical condition that preclude participation at investigator criteria Allergy or hypersensitivity to salicylates Previous or concomitant treatment for ulcerative colitis interfering with safety or activity assessments</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>65 Years</maximum_age>
	<verification_date>November 2010</verification_date>
</DOC>